Falling crude oil prices sent the markets tumbling to a sharply lower close with the Dow plunging 131 points to 18,261. Nasdaq dropped 33 points to 5,305.
On the upside
BioLineRx (Nasdaq: BLRX) signed an exclusive, global agreement with BGN Technologies, the Technology Transfer Company of Ben-Gurion Universioty and Hadasit for the in-licensing of the liver failure treatment BL-1220.
Shares of Apptio (Nasdaq: APTI) soared in its market debut.
AC Immune (Nasdaq: ACIU) stock surged on its first trading day.
On the downside
Digital Turbine (Nasdaq: APPS) priced its private placement of convertible senior notes.
Oshkosh (NYSE: OSK) warned of lower revenue in its access equipment segment for 2017.
Shares of Corbus Pharmaceuticals (Nasdaq: CRBP) continued to fall.
In the broad market, declining issues outpaced advancers by a margin of more than 5 to 3 on the NYSE and by more than 3 to 2 on Nasdaq. The broader S&P 500 dropped 12 points to 2,164. Bitcoin climbed $5 to $602
